227 related articles for article (PubMed ID: 7955862)
1. MR-appearance of the pituitary gland before and after resection of pituitary macroadenomas.
Steiner E; Math G; Knosp E; Mostbeck G; Kramer J; Herold CJ
Clin Radiol; 1994 Aug; 49(8):524-30. PubMed ID: 7955862
[TBL] [Abstract][Full Text] [Related]
2. MRI of pituitary adenomas: the position of the normal pituitary gland.
Sumida M; Uozumi T; Mukada K; Arita K; Kurisu K; Yano T; Onda J; Satoh H; Ikawa F
Neuroradiology; 1994 May; 36(4):295-7. PubMed ID: 8065574
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenomas: findings of postoperative MR imaging.
Steiner E; Knosp E; Herold CJ; Kramer J; Stiglbauer R; Staniszewski K; Imhof H
Radiology; 1992 Nov; 185(2):521-7. PubMed ID: 1410366
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma.
Kremer P; Forsting M; Ranaei G; Wüster C; Hamer J; Sartor K; Kunze S
Acta Neurochir (Wien); 2002 May; 144(5):433-43. PubMed ID: 12111499
[TBL] [Abstract][Full Text] [Related]
5. Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging.
Miki Y; Matsuo M; Nishizawa S; Kuroda Y; Keyaki A; Makita Y; Kawamura J
Radiology; 1990 Oct; 177(1):35-8. PubMed ID: 2399335
[TBL] [Abstract][Full Text] [Related]
6. Normal and abnormal pituitary glands: gadopentetate dimeglumine-enhanced MR imaging.
Sakamoto Y; Takahashi M; Korogi Y; Bussaka H; Ushio Y
Radiology; 1991 Feb; 178(2):441-5. PubMed ID: 1987606
[TBL] [Abstract][Full Text] [Related]
7. A clinical and histopathological study of factors affecting MRI signal intensities of pituitary adenomas.
Kobayashi S; Ikeda H; Yoshimoto T
Neuroradiology; 1994 May; 36(4):298-302. PubMed ID: 8065575
[TBL] [Abstract][Full Text] [Related]
8. Rathke cleft cysts: correlation of enhanced MR and surgical findings.
Sumida M; Uozumi T; Mukada K; Arita K; Kurisu K; Eguchi K
AJNR Am J Neuroradiol; 1994 Mar; 15(3):525-32. PubMed ID: 8197952
[TBL] [Abstract][Full Text] [Related]
9. Gd-DTPA-enhanced MR imaging of pituitary macroadenomas.
Lundin P; Bergström K
Acta Radiol; 1992 Jul; 33(4):323-32. PubMed ID: 1633042
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-DTPA and MR imaging of pituitary adenoma: a preliminary report.
Davis PC; Hoffman JC; Malko JA; Tindall GT; Takei Y; Avruch L; Braun IF
AJNR Am J Neuroradiol; 1987; 8(5):817-23. PubMed ID: 3118674
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging of tuberculum sellae meningiomas: preventing preoperative misdiagnosis as pituitary macroadenoma.
Taylor SL; Barakos JA; Harsh GR; Wilson CB
Neurosurgery; 1992 Oct; 31(4):621-7; discussion 627. PubMed ID: 1407446
[TBL] [Abstract][Full Text] [Related]
12. MR imaging of residual tumor tissue after transsphenoidal surgery of hormone-inactive pituitary macroadenomas: a prospective study.
Kremer P; Forsting M; Hamer J; Sartor K
Acta Neurochir Suppl; 1996; 65():27-30. PubMed ID: 8738489
[TBL] [Abstract][Full Text] [Related]
13. MRI of pituitary adenomas in acromegaly.
Marro B; Zouaoui A; Sahel M; Crozat N; Gerber S; Sourour N; Sag K; Marsault C
Neuroradiology; 1997 Jun; 39(6):394-9. PubMed ID: 9225316
[TBL] [Abstract][Full Text] [Related]
14. Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR.
Lundin P; Edén Engström B; Karlsson FA; Burman P
AJNR Am J Neuroradiol; 1997 Apr; 18(4):765-72. PubMed ID: 9127047
[TBL] [Abstract][Full Text] [Related]
15. The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas.
Nakamura T; Schörner W; Bittner RC; Felix R
Neuroradiology; 1988; 30(6):481-6. PubMed ID: 3226534
[TBL] [Abstract][Full Text] [Related]
16. Improving postoperative MR imaging of pituitary macroadenomas: comparison of full and reduced dose of gadopentetate dimeglumine.
Hald JK; Eldevik OP; Dunn RL; Bakke SJ; Pedersen HK; Nakstad PH
Eur Radiol; 2000; 10(7):1068-72. PubMed ID: 11003399
[TBL] [Abstract][Full Text] [Related]
17. [Gd-DTPA in the MR diagnosis of pituitary adenomas].
Steiner E; Wimberger D; Imhof H; Knosp E; Hajek P
Rofo; 1989 Mar; 150(3):323-7. PubMed ID: 2538883
[TBL] [Abstract][Full Text] [Related]
18. Effect of dose and field strength on enhancement with paramagnetic contrast media.
Lindsey RO; Yetkin FZ; Prost R; Haughton VM
AJNR Am J Neuroradiol; 1994 Nov; 15(10):1849-52. PubMed ID: 7863934
[TBL] [Abstract][Full Text] [Related]
19. Varied microcirculation of pituitary adenomas at rapid, dynamic, contrast-enhanced MR imaging.
Finelli DA; Kaufman B
Radiology; 1993 Oct; 189(1):205-10. PubMed ID: 8372195
[TBL] [Abstract][Full Text] [Related]
20. Gd-DTPA-enhanced MR imaging of pituitary adenomas.
Newton DR; Dillon WP; Norman D; Newton TH; Wilson CB
AJNR Am J Neuroradiol; 1989; 10(5):949-54. PubMed ID: 2505539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
